User menu

Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study

Bibliographic reference Siena, Salvatore ; Douillard, Jean-Yves ; Tabernero, Josef ; Cassidy, James ; Burkes, Ronald ; et. al. Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study.In: Onkologie : international journal for cancer research and treatment, Vol. 33, p. 68-69 (2010)
Permanent URL http://hdl.handle.net/2078.1/58598